ZIG
APLM icon

Zullo Investment Group’s Apollomics APLM Stock Holding History

Zullo Investment Group’s Portfolio APLM Stock Details APLM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-149
Closed -$14.3K – 155
2023
Q4 		$14.3K Buy
+149
New +$18.3K 0.01% 147

Other funds holding APLM

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
PIA
Powell Investment Advisors Miami, Florida $290M AUM 21.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
B
Bensler Bellevue, Washington $1.13B AUM 38.91% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Zullo Investment Group's APLM Position: Q1 2024 in Review

Zullo Investment Group sold out of Apollomics (APLM) in Q1 2024, closing a stake of 149 shares — an estimated $14.3K sold.

Zullo Investment Group first reported a position in APLM in Q4 2023 and held it in 1 quarter. The position peaked at $14.3K in Q4 2023. 12 funds tracked by Wall St. Rank hold APLM as of Q1 2024.

  • Zullo Investment Group reported no remaining Apollomics position as of Q1 2024 after selling out during the quarter.
  • Zullo Investment Group sold 149 Apollomics shares in Q1 2024, an estimated $14.3K.
  • Zullo Investment Group first reported a position in Apollomics in Q4 2023 and held it in 1 quarter.
  • Zullo Investment Group's Apollomics position peaked at $14.3K in Q4 2023.
  • 12 funds tracked by Wall St. Rank held Apollomics as of Q1 2024.

Based on Zullo Investment Group's 13F filing for Q1 2024, filed 24 Apr 2024.